Group 1 - The company, Olin Bio (688319.SH), is planning to issue overseas shares (H-shares) and apply for listing on the Hong Kong Stock Exchange to enhance its international presence and influence [1] - This initiative is part of the company's strategy to deepen its internationalization efforts and optimize its capital structure [1] - The goal of this move is to strengthen the company's overall competitiveness in the market [1]

Core Viewpoint - Beida Pharmaceutical plans to issue overseas listed shares (H-shares) and apply for listing on the Hong Kong Stock Exchange to enhance its capital strength and competitiveness while advancing its internationalization process [1] Group 1: Company Actions - The company aims to consider the interests of existing shareholders and the conditions of domestic and international capital markets during the issuance process [1] - The issuance and listing will be completed at an appropriate time and issuance window within the validity period of the shareholders' meeting resolution, which is 18 months from the approval date or any extended period agreed upon [1]

Core Viewpoint - The company has announced the establishment of a wholly-owned subsidiary in the United States to advance its internationalization strategy, with a registered capital of $20,000 [1] Group 1: Company Development - The subsidiary is named GOALAND THERMAL MANAGEMENT TECHNOLOGY US ALTD and has been registered in California [1] - The investment is funded by the company's own resources and will not adversely affect its production and operations [1]